Year: 2024
Type: article
Abstract: Background: For decades, the implantable artificial kidney (WAK) symbolized the highest standard of kidney failure treatments. The innovations that allowed for the development of both WAK V1.0 and its more advanced variations, V1.1 and 1.2, are explained here. Modern developments have the potential to change the traditional paradigm for managing renal failure. The US Food and Drug Administration is committed to using accurate research regarding how patients evaluate the advantages and disadvantages of new devices in deciding on them, but there hasn't been much premarket patient preference information (PPI) accepted for renal devices up to this date. They have designed a survey with input from stakeholders with the objective of creating reliable PPI, including how patients balance the potential benefits and drawbacks of in-center hemodialysis and wearable dialysis equipment.
Author: Ms. Shalini Franky
Institution: Sharda University
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4402938014